Counterfeit Botox Found in U.S.A.
A counterfeit version of Botox has been found in the United States and may have reached physicians’ offices and medical clinics nationwide, per a warning from the US Food and Drug Administration.
“The product was sold by an unlicensed supplier who is not authorized to ship or distribute drug products in the United States. The counterfeit products are considered unsafe and should not be used. FDA cannot confirm that the manufacture, quality, storage, and handling of these suspect products follow U.S. standards,” the agency said in a news release.
One of the biggest dangers of counterfeit Botox is that it can use human albumin, which runs the risk of transmitting HIV or Hepatitis C to the person that receives the fraudulent product. Though the FDA is not aware of any adverse events associated with the counterfeit version of Botox at this time, it’s important to be cautious.
“Currently, there is no indication that Allergan’s FDA-approved version is at risk, and the genuine product should be considered safe and effective for its intended and approved uses,” the FDA said.
Our customers can rest assure that we always purchase our injectable neuromodulators – like Botox (Allergan), Dysport (Medicis), and Xeomin (Merz) – directly from the supplier. It is very important to always make sure you are receiving the approved U.S. version of these products. If you suspect you might be receiving a counterfeit version, we would encourage you to call Allergan, Galderma, or Merz directly to make sure your provider has an account with the company.
The FDA is asking the public to report suspect Botox products by calling the FDA’s Office of Criminal Investigations at 800-551-3989, online at http://www.accessdata.fda.gov/scripts/email/oc/oci/contact.cfm, or by email at DrugSupplyChainIntegrity@fda.hhs.gov.